Blood protein patterns in stomach cancer for treatment guidance
Part of Cancer, Digestive system clinical trials.
This trial looks at protein patterns in the blood of people with stomach cancer. The goal is to find out if these patterns can help guide treatment, especially before surgery. It is for people with a certain type of stomach cancer that has not spread to distant organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with gastric adenocarcinoma (a common type of stomach cancer).
- Your tumor is in the upper stomach or at the junction with the esophagus.
- Your cancer is at a stage where it has grown into or through the stomach wall and may have spread to nearby lymph nodes, but not to other organs.
- You are well enough to do most daily activities (KPS score of 80 or more).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study is testing a new way to find stomach (gastric) cancer early using a simple blood test. It may help people who have just been diagnosed with stage I, II, or III stomach cancer and have not started treatment yet.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study uses a simple blood test to look for signs of stomach (gastric) cancer early. It may help detect cancer before symptoms appear, potentially improving treatment success.
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.